Publication:
Long-term effects of varying consumption of ω3 fatty acids in ear, nose and throat cancer patients: assessment 1 year after radiotherapy.

Simple item page
dc.contributor.authorRoca-Rodríguez, María del Mar
dc.contributor.authorGarcía-Almeida, José Manuel
dc.contributor.authorRuiz-Nava, Josefina
dc.contributor.authorAlcaide, Juan
dc.contributor.authorLupiáñez-Pérez, Yolanda
dc.contributor.authorRico-Pérez, José Manuel
dc.contributor.authorToledo-Serrano, María Dolores
dc.contributor.authorCardona, Fernando
dc.contributor.authorMedina-Carmona, José Antonio
dc.contributor.authorTinahones, Francisco J
dc.contributor.authoraffiliation[Roca-Rodríguez,MM; Alcaide,J; Cardona,F; Tinahones,FJ] Biomedical Research Institute of Málaga (IBIMA),Virgen de la Victoria Hospital, University of Málaga, Spain. [Roca-Rodríguez,MM; García-Almeida,JM; Ruiz-Nava,J; Tinahones,FJ] Department of Endocrinology and Nutrition, Virgen de la Victoria Hospital, Málaga, Spain. [Lupiáñez-Pérez,Y; Rico-Pérez,JM; Toledo-Serrano,MD; Medina Carmona,JA] Department of Clinical and Radiotherapeutic Oncology, Virgen de la Victoria Hospital, Málaga, Spain. [Roca-Rodríguez,MM; Cardona,F; Tinahones,FJ] Biomedical Research Center of Physiopathology of Obesity and Nutrition (CIBER CB06/003), Carlos III Health Institute. Madrid, Spain.es
dc.contributor.funderM. Mar Roca-Rodríguez is supported by a fellowship from the Rio Hortega CM11/00030 Program from the Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness.
dc.date.accessioned2016-04-01T11:04:18Z
dc.date.available2016-04-01T11:04:18Z
dc.date.issued2015-02
dc.descriptionJournal Article;es
dc.description.abstractAbstract A prospective 1-year follow-up study in ear, nose, and throat (ENT) cancer patients was carried out one year after radiotherapy to assess the effect of varying consumption of ω3 fatty acid according to whether they consumed more or less than the 50th percentile of ω3 fatty acids. Clinical, analytical, inflammatory (CRP and IL-6), and oxidative variables (TAC, GPx, GST, and SOD) were evaluated. The study comprised 31 patients (87.1% men), with a mean age of 61.3 ± 9.1 years. Hematological variables showed significant differences in the patients with a lower consumption of ω3 fatty acids. A lower mortality and longer survival were found in the group with ω3 fatty acid consumption ≥50th percentile but the differences were not significant. No significant difference was reached in toxicity, inflammation, and oxidative stress markers. The group with ω3 fatty acid consumption <50th percentile significantly experienced more hematological and immune changes.es
dc.description.versionYeses
dc.identifier.citationRoca-Rodríguez M del M, García-Almeida JM, Ruiz-Nava J, Alcaide J, Lupiañez-Pérez Y, Rico-Pérez JM, et al. Long-term effects of varying consumption of ω3 fatty acids in ear, nose and throat cancer patients: assessment 1 year after radiotherapy. Int J Food Sci Nutr. 2015; 66(1):108-13es
dc.identifier.doi10.3109/09637486.2014.953453
dc.identifier.essn1465-3478
dc.identifier.issn0963-7486
dc.identifier.pmid25265206
dc.identifier.urihttp://hdl.handle.net/10668/2169
dc.journal.titleInternational Journal of Food Sciences and Nutrition
dc.language.isoen
dc.publisherInforma Healthcarees
dc.relation.publisherversionhttp://informahealthcare.com/doi/abs/10.3109/09637486.2014.953453es
dc.rights.accessRightsopen access
dc.subjectNutritional supplementes
dc.subjectCanceres
dc.subjectClinical studyes
dc.subjectMetabolic statuses
dc.subjectSurvivales
dc.subjectAntioxidanteses
dc.subjectMarcadores biológicoses
dc.subjectÍndice de masa corporales
dc.subjectProteina C reactivaes
dc.subjectSuplementos dietéticoses
dc.subjectCáncer de oídoes
dc.subjectElectrolitoses
dc.subjectÁcidos grasos insaturadoses
dc.subjectGlutatión peroxidasaes
dc.subjectPeróxido de hidrógenoes
dc.subjectInflamaciónes
dc.subjectInterleucina-6es
dc.subjectDesnutriciónes
dc.subjectNeoplasias nasaleses
dc.subjectEstres oxidativoes
dc.subjectNeoplasias faríngeases
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Antioxidantses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Biological Factors::Biological Markerses
dc.subject.meshMedical Subject Headings::Health Care::Environment and Public Health::Public Health::Epidemiologic Measurements::Biometry::Anthropometry::Body Mass Indexes
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Albumins::C-Reactive Proteines
dc.subject.meshMedical Subject Headings::Technology, Industry, Agriculture::Food and Beverages::Food::Dietary Fiberes
dc.subject.meshMedical Subject Headings::Technology, Industry, Agriculture::Food and Beverages::Food::Dietary Supplementses
dc.subject.meshMedical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms::Otorhinolaryngologic Neoplasms::Ear Neoplasmses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Inorganic Chemicals::Electrolyteses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids, Unsaturatedes
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Oxidoreductases::Peroxidases::Glutathione Peroxidasees
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Inorganic Chemicals::Electrolytes::Ions::Anions::Oxides::Peroxides::Hydrogen Peroxidees
dc.subject.meshMedical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Inflammationes
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Cytokines::Interleukins::Interleukin-6es
dc.subject.meshMedical Subject Headings::Diseases::Nutritional and Metabolic Diseases::Nutrition Disorders::Malnutritiones
dc.subject.meshMedical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms::Otorhinolaryngologic Neoplasms::Nose Neoplasmses
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Metabolic Phenomena::Metabolism::Oxidative Stresses
dc.subject.meshMedical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms::Otorhinolaryngologic Neoplasms::Pharyngeal Neoplasmses
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses
dc.titleLong-term effects of varying consumption of ω3 fatty acids in ear, nose and throat cancer patients: assessment 1 year after radiotherapy.es
dc.typeresearch article
dc.type.hasVersionSMUR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Roca_Long_term.pdf
Size:
493.07 KB
Format:
Adobe Portable Document Format
Description:
Pre-print (Versión del autor)
Download

Collections

SAS - Hospital Universitario Virgen de la Victoria

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía